Literature DB >> 11323475

Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography.

I Vizcaíno1, L Gadea, L Andreo, D Salas, F Ruiz-Perales, D Cuevas, C Herranz, F Bueno.   

Abstract

PURPOSE: To evaluate short-term follow-up of nonpalpable probably benign lesions in a 2-year mammographic screening.
MATERIALS AND METHODS: Of 13,790 women aged 45-65 years who underwent first-round screening, 795 (5.8%) underwent short-term mammographic follow-up (every 6 months for 2 years) of nonpalpable probably benign lesions (eg, masses, focal asymmetric densities, and calcifications) previously assessed at an additional imaging evaluation, including ultrasonography. When no changes were found at short-term mammographic follow-up, women were assigned to the 2-year screening interval. Needle localization and surgical biopsy were performed when the lesion progressed (was enlarged or had an increased number or size of calcifications or modification of their initial characteristics). The effectiveness of this approach was evaluated with statistical analysis.
RESULTS: Of 795 lesions, 788 (99%) remained stable, and seven (1%) had changes prompting surgical biopsy. Two cancers (0.3%), one microinvasive intraductal carcinoma and one 7-mm invasive ductal carcinoma without positive nodes, were found. Four of the five benign histologic results were probably benign calcifications with progression at short-term follow-up. The sensitivity, specificity, accuracy, and positive and negative predictive values were 100%, 99%, 99%, 29%, and 100%, respectively.
CONCLUSION: The benign nature of most nonpalpable probably benign lesions can be typified with short-term mammographic follow-up. This approach permitted identification of a few low-stage carcinomas, but progression in the probably benign calcifications was usually unrelated to malignancy.

Entities:  

Mesh:

Year:  2001        PMID: 11323475     DOI: 10.1148/radiology.219.2.r01ma11475

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  32 in total

Review 1.  Stereotactic and ultrasound-guided breast biopsy.

Authors:  T H Helbich; W Matzek; M H Fuchsjäger
Journal:  Eur Radiol       Date:  2003-11-13       Impact factor: 5.315

2.  Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.

Authors:  Susan P Weinstein; Lucy G Hanna; Constantine Gatsonis; Mitchell D Schnall; Mark A Rosen; Constance D Lehman
Journal:  Radiology       Date:  2010-06       Impact factor: 11.105

3.  Optimization of contrast-enhanced spectral mammography depending on clinical indication.

Authors:  Clarisse Dromain; Sandra Canale; Sylvie Saab-Puong; Ann-Katherine Carton; Serge Muller; Eva Maria Fallenberg
Journal:  J Med Imaging (Bellingham)       Date:  2014-12-30

4.  Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients.

Authors:  Hye Mi Gweon; Nariya Cho; Soo-Yeon Kim; Hye Ryoung Koo; Mirinae Seo; Ajung Chu; Eun Ju Son
Journal:  Eur Radiol       Date:  2017-01-12       Impact factor: 5.315

5.  The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions.

Authors:  Mehmet U S Ayvaci; Oguzhan Alagoz; Elizabeth S Burnside
Journal:  Manuf Serv Oper Manag       Date:  2012-04       Impact factor: 7.600

6.  Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy.

Authors:  Amy Lynn Conners; Carrie B Hruska; Cindy L Tortorelli; Robert W Maxwell; Deborah J Rhodes; Judy C Boughey; Wendie A Berg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06       Impact factor: 9.236

7.  Additional diagnostic value of MRI in patients with suspicious breast lesions based on ultrasound.

Authors:  O Sarica; F Uluc
Journal:  Br J Radiol       Date:  2014-07-01       Impact factor: 3.039

8.  Multiple bilateral circumscribed masses at screening breast US: consider annual follow-up.

Authors:  Wendie A Berg; Zheng Zhang; Jean B Cormack; Ellen B Mendelson
Journal:  Radiology       Date:  2013-04-24       Impact factor: 11.105

9.  Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 18-month experience with telemedicine screening.

Authors:  Ruwan A Silva; Yohko Murakami; Atul Jain; Jarel Gandhi; Eleonora M Lad; Darius M Moshfeghi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-11       Impact factor: 3.117

10.  Validation of results from knowledge discovery: mass density as a predictor of breast cancer.

Authors:  Ryan W Woods; Louis Oliphant; Kazuhiko Shinki; David Page; Jude Shavlik; Elizabeth Burnside
Journal:  J Digit Imaging       Date:  2009-09-16       Impact factor: 4.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.